Aside from these scenarios in niches, numerous signaling pathways in BCR-ABL dependent and independent manner are ongoing and should be taken into account in baring the facts of CML LSC persistence. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.